keyword
https://read.qxmd.com/read/38618830/value-based-integrated-care-a-systematic-literature-review
#21
JOURNAL ARTICLE
Evelien S van Hoorn, Lizhen Ye, Nikki van Leeuwen, Hein Raat, Hester F Lingsma
BACKGROUND: Healthcare services worldwide are transforming themselves into value-based organizations. Integrated care is an important aspect of value-based healthcare (VBHC), but practical evidence-based recommendations for the successful implementation of integrated care within a VBHC context are lacking. This systematic review aims to identify how value-based integrated care (VBIC) is defined in literature, and to summarize the literature regarding the effects of VBIC, and the facilitators and barriers for its implementation...
2024: International Journal of Health Policy and Management
https://read.qxmd.com/read/38615938/it-takes-two-to-tango-setting-out-the-conditions-in-which-performance-based-risk-sharing-arrangements-work-for-both-parties
#22
JOURNAL ARTICLE
Adrian Towse, Elisabeth Fenwick
OBJECTIVES: Faster regulatory approval processes often fail to achieve faster patient access. We seek an approach, using performance-based risk-sharing arrangements (PBRSA), to address uncertainty for payers regarding the relative effectiveness and value for money of products launched through accelerated approval schemes. One important reason for risk-sharing is to resolve differences of opinion between innovators and payers about a technology's underlying value. To date, there has been no formal attempt to set out the circumstances in which risk-sharing can address these differences...
April 12, 2024: Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research
https://read.qxmd.com/read/38589990/merit-based-incentive-payment-system-how-are-plastic-surgeons-performing
#23
JOURNAL ARTICLE
Sofia Perez Otero, Allison L Diaz, Kshipra Hemal, Carter J Boyd, Wen-Yu Lee, Nolan S Karp
PURPOSE: Merit-based incentive payment system (MIPS) is a payment model implemented to promote high-value care through performance-based adjustments of Medicare reimbursements. Higher scores indicate superior performance in healthcare quality, efficiency, and interoperability, which can result in financial advantages. Given the paucity of literature, we aimed to characterize plastic surgery performance in MIPS. METHOD: The Centers for Medicare and Medicaid Services (CMS) online data repository was queried for data on MIPS performance of plastic surgeons from 2019-2021...
April 9, 2024: Plastic and Reconstructive Surgery
https://read.qxmd.com/read/38559704/using-claims-data-to-predict-pre-operative-bmi-among-bariatric-surgery-patients-development-of-the-bmi-before-bariatric-surgery-scoring-system-b3s3
#24
JOURNAL ARTICLE
Jenna Wong, Xiaojuan Li, David E Arterburn, Dongdong Li, Elizabeth Messenger-Jones, Rui Wang, Sengwee Toh
BACKGROUND: Lack of body mass index (BMI) measurements limits the utility of claims data for bariatric surgery research, but pre-operative BMI may be imputed due to existence of weight-related diagnosis codes and BMI-related reimbursement requirements. We used a machine learning pipeline to create a claims-based scoring system to predict pre-operative BMI, as documented in the electronic health record (EHR), among patients undergoing a new bariatric surgery. METHODS: Using the Optum Labs Data Warehouse, containing linked de-identified claims and EHR data for commercial or Medicare Advantage enrollees, we identified adults undergoing a new bariatric surgery between January 2011 and June 2018 with a BMI measurement in linked EHR data ≤30 days before the index surgery (n=3226)...
2024: Pragmatic and Observational Research
https://read.qxmd.com/read/38558740/development-of-the-emirates-multi-criteria-decision-analysis-tool-for-orphan-drugs
#25
JOURNAL ARTICLE
Khalid A Alnaqbi, Baher Elezbawy, Ahmad N Fasseeh, Abdul Rauf Bangash, Amin Elshamy, Hiba Shendi, Mohammed I Aftab, Mozah AlMarshoodi, Nicole Gebran, Noura AlDhaheri, Sahar A Fahmy, Sara Al Dallal, Waeil Al Naeem, Sherif Abaza, Zoltán Kaló
Background The number of orphan drug approvals is currently increasing globally. This creates a significant burden on payers and healthcare systems. This study aimed to create a multi-criteria decision analysis (MCDA) tool for evaluating orphan drugs within the United Arab Emirates (UAE). The intended result of the tool is to provide evidence-based guidance to decision-makers in reimbursement and procurement decisions. Methods We conducted a literature search and local expert interviews to identify relevant preliminary criteria for the MCDA tool...
February 2024: Curēus
https://read.qxmd.com/read/38556037/primary-care-its-pokemon-moment
#26
REVIEW
Bryan Becker
Primary care in the United States is undergoing bursts of evolution in response to health system stresses, changing demographics, and expansion of risk and value-based reimbursement structures. The impact of primary care remains substantive and associated with improved population health. However, the spectrum of services, the nature of the physicians involved and new ways of including the patient in her, or his own care suggests that a new definition of primary care be considered, and patient expectations be heeded and understood...
March 29, 2024: American Journal of Medicine
https://read.qxmd.com/read/38518868/editorial-utilization-of-knee-arthroscopy-for-degenerative-meniscus-tears-is-on-the-decline-alongside-reimbursements-rates
#27
EDITORIAL
Nicole D Rynecki, Lefko Charalambous, Michael J Alaia
In recent years, there has been a shift in healthcare away from the fee-for-service model to a value-based care model. Concomitantly, there have been changes in inflation-adjusted surgeon reimbursements for arthroscopic meniscectomies. Nationally, albeit at different rates, there has been a decrease in partial meniscectomy utilization. We feel that this is in part due to the change in healthcare economics and reimbursements as well as the growing evidence that partial meniscectomy may not be as efficacious in the treatment of degenerative meniscus tears as we once thought...
March 20, 2024: Arthroscopy
https://read.qxmd.com/read/38512121/new-reimbursement-models-to-promote-better-patient-outcomes-and-overall-value-in-laboratory-medicine-and-healthcare
#28
JOURNAL ARTICLE
Tommaso Trenti, Anna Maria Petrini, Mario Plebani
The most widespread healthcare reimbursement models, including diagnostic laboratory services, are Fee-for-Service, Reference Pricing and Diagnosis-Related Groups. Within these models healthcare providers are remunerated for each specific service or procedure they operate. Healthcare payers are increasingly exploring alternative models, such as bundled payments or value-based reimbursement to encourage value of patient care rather than the simple amount of delivered services. These alternative models are advised, as they are more efficient in promoting cost-effective, high-quality laboratory testing, thereby improving patient health outcomes...
March 22, 2024: Clinical Chemistry and Laboratory Medicine: CCLM
https://read.qxmd.com/read/38492098/impact-of-reimbursement-systems-on-patient-care-a-systematic-review-of-systematic-reviews
#29
REVIEW
Eva Wagenschieber, Dominik Blunck
BACKGROUND: There is not yet sufficient scientific evidence to answer the question of the extent to which different reimbursement systems influence patient care and treatment quality. Due to the asymmetry of information between physicians, health insurers and patients, market-based mechanisms are necessary to ensure the best possible patient care. The aim of this study is to investigate how reimbursement systems influence multiple areas of patient care in form of structure, process and outcome indicators...
March 16, 2024: Health Economics Review
https://read.qxmd.com/read/38485174/low-value-mri-of-the-knee-in-norway-a-register-based-study-to-identify-the-proportion-of-potentially-low-value-mris-and-estimate-the-related-costs
#30
JOURNAL ARTICLE
Bjørn Hofmann, Vegard Håvik, Eivind Richter Andersen, Ingrid Øfsti Brandsæter, Elin Kjelle
OBJECTIVES: The objective of this study is to investigate the proportion of potentially low-value knee MRI in Norway and to provide an estimate of the related costs. DESIGN: Register study based on conditional data extraction and analysis of data from Control and Reimbursement of Healthcare Claims registry in Norway. SETTING: MRI in public specialist healthcare with universal health coverage (Norway). PARTICIPANTS: 48 212 MRIs for 41 456 unique patients and 45 946 reimbursement claims...
March 13, 2024: BMJ Open
https://read.qxmd.com/read/38480616/economic-value-of-diastasis-repair-with-the-use-of-mesh-compared-to-no-intervention-in-italy
#31
JOURNAL ARTICLE
Carla Rognoni, Alessandro Carrara, Micaela Piccoli, Vincenzo Trapani, Nereo Vettoretto, Giorgio Soliani, Rosanna Tarricone
AIM: Rectus abdominal diastasis (RAD) can cause mainly incontinence and lower-back pain. Despite its high incidence, there is no consensus regarding surgical indication. We aimed at comparing RAD repair (minimally invasive technique with mesh implant) with no treatment (standard of care - SOC) through cost-effectiveness and budget impact analyses from both National Healthcare Service (NHS) and societal perspectives in Italy. METHODS: A model was developed including social costs and productivity losses derived by the online administration of a socio-economic questionnaire, including the EuroQol for the assessment of quality of life...
March 14, 2024: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://read.qxmd.com/read/38464480/cemiplimab-in-locally-advanced-or-metastatic-cutaneous-squamous-cell-carcinoma-prospective-real-world-data-from-the-drug-access-protocol
#32
JOURNAL ARTICLE
Karlijn Verkerk, Birgit S Geurts, Laurien J Zeverijn, Vincent van der Noort, Henk M W Verheul, John B A G Haanen, Astrid A M van der Veldt, Ferry A L M Eskens, Maureen J B Aarts, Carla M L van Herpen, Mathilde Jalving, Jourik A Gietema, Lot A Devriese, Mariette Labots, Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Egbert F Smit, Haiko J Bloemendal
BACKGROUND: The DRUG Access Protocol provides patients with cancer access to registered anti-cancer drugs that are awaiting reimbursement in the Netherlands and simultaneously collects prospective real-world data (RWD). Here, we present RWD from PD-1 blocker cemiplimab in patients with locally advanced or metastatic cutaneous squamous cell carcinoma (laCSCC; mCSCC). METHODS: Patients with laCSCC or mCSCC received cemiplimab 350 mg fixed dose every three weeks...
April 2024: The Lancet regional health. Europe
https://read.qxmd.com/read/38462731/factors-associated-with-the-maintenance-of-cost-effectiveness-at-5-years-in-adult-spinal-deformity-corrective-surgery
#33
JOURNAL ARTICLE
Peter G Passias, Jamshaid M Mir, Pooja Dave, Justin S Smith, Renaud Lafage, Jeffrey Gum, Breton G Line, Bassel Diebo, Alan H Daniels, David Kojo Hamilton, Thomas J Buell, Justin K Scheer, Robert K Eastlack, Jeffrey P Mullin, Gregory M Mundis, Naobumi Hosogane, Mitsuru Yagi, Andrew J Schoenfeld, Juan S Uribe, Neel Anand, Praveen V Mummaneni, Dean Chou, Eric O Klineberg, Khaled M Kebaish, Stephen J Lewis, Munish C Gupta, Han Jo Kim, Robert A Hart, Lawrence G Lenke, Christopher P Ames, Christopher I Shaffrey, Frank J Schwab, Virginie Lafage, Richard A Hostin, Shay Bess, Douglas C Burton
STUDY DESIGN: Retrospective cohort. OBJECTIVE: To evaluate factors associated with the long-term durability of cost-effectiveness (CE) in ASD patients. BACKGROUND: A substantial increase in costs associated with the surgical treatment for adult spinal deformity (ASD) has given precedence to scrutinize the value and utility it provides. METHODS: We included 327 operative ASD patients with 5-year (5 Y) follow-up. Published methods were used to determine costs based on CMS...
March 11, 2024: Spine
https://read.qxmd.com/read/38447743/understanding-the-nice-severity-premium-exploring-its-implementation-and-the-implications-for-decision-making-and-patient-access
#34
JOURNAL ARTICLE
Martin W Njoroge, Matthew Walton, Robert Hodgson
OBJECTIVE: To evaluate the impact of NICE's new severity modifier, which has replaced the end-of-life (EoL) premium, on future NICE recommendations, considering past decision-making patterns. METHODS: NICE technology appraisals (TAs) published between January 2020 and December 2022 were reviewed. Summary statistics were generated to assess how the new severity modifier might impact hypothetical decision-making in historical TAs. RESULTS: A total of 138 data points were identified from 132 TAs...
March 4, 2024: Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research
https://read.qxmd.com/read/38446594/resource-utilization-following-anterior-versus-posterior-cervical-decompression-and-fusion-for-acute-central-cord-syndrome
#35
JOURNAL ARTICLE
Jerry Y Du, Karim Shafi, Collin W Blackburn, Jens R Chapman, Nicholas U Ahn, Randall E Marcus, Todd J Albert
STUDY DESIGN: Retrospective cohort study. OBJECTIVE: The purpose of this study is to compare the impact of anterior cervical decompression and fusion (ACDF) versus posterior cervical decompression and fusion (PCDF) for the treatment of acute traumatic central cord syndrome (CCS) on hospital episodes of care in terms of (1) cost, (2) length of hospital stay, and (3) discharge destination. SUMMARY OF BACKGROUND DATA: Acute traumatic CCS is the most common form of spinal cord injury in the United States...
March 1, 2024: Clinical Spine Surgery
https://read.qxmd.com/read/38439068/values-challenges-and-responses-associated-with-high-priced-potential-cures-perspectives-of-diverse-stakeholders-in-south-korea
#36
JOURNAL ARTICLE
Jihyung Hong, Eun-Young Bae, Hye-Jae Lee, Tae-Jin Lee, Philip Clarke
BACKGROUND: The emergence of high-priced potential cures has sparked significant health policy discussions in South Korea, where the healthcare system is funded through a single-payer National Health Insurance model. We conducted focus group interviews (FGIs) and accompanying surveys with diverse stakeholders to comprehensively understand related issues and find better solutions to the challenges brought by these technologies. METHODS: From October to November 2022, 11 FGIs were conducted with stakeholders from various sectors, including government payers, policy and clinical experts, civic and patient organisations, and the pharmaceutical industry, involving a total of 25 participants...
March 4, 2024: Cost Effectiveness and Resource Allocation: C/E
https://read.qxmd.com/read/38438250/development-and-validation-of-algorithms-to-predict-left-ventricular-ejection-fraction-class-from-healthcare-claims-data
#37
JOURNAL ARTICLE
Damien Logeart, Maxime Doublet, Margaux Gouysse, Thibaud Damy, Richard Isnard, François Roubille
AIMS: The use of large medical or healthcare claims databases is very useful for population-based studies on the burden of heart failure (HF). Clinical characteristics and management of HF patients differ according to categories of left ventricular ejection fraction (LVEF), but this information is often missing in such databases. We aimed to develop and validate algorithms to identify LVEF in healthcare databases where the information is lacking. METHODS AND RESULTS: Algorithms were built by machine learning with a random forest approach...
March 4, 2024: ESC Heart Failure
https://read.qxmd.com/read/38435347/cost-effectiveness-analysis-of-margin-controlled-surgery-for-vulvar-paget-s-disease
#38
JOURNAL ARTICLE
Kelly H Bruce, James P Moriarty, Bijan J Borah, Ruchita Dholakia, Mary E Lohman, Jerry D Brewer, Nahid Y Vidal, Jamie N Bakkum-Gamez, William A Cliby
OBJECTIVES: To determine the cost of two surgical treatment approaches for vulvar Paget's disease and model the cost-effectiveness considering differences in recurrence and reoperation over time. METHODS: We assessed cost-effectiveness between excision guided by Mohs micrographic surgery (MMS-E) and traditional wide local excision (WLE). We examined billing data from patients with vulvar Paget's disease who underwent MMS-E (cases, n = 24, 2018-2022) or WLE (controls, n = 64, 1990-2020)...
April 2024: Gynecologic Oncology Reports
https://read.qxmd.com/read/38433808/the-cost-of-ambulatory-breast-reduction-hospital-reimbursement-versus-surgeon-payments
#39
JOURNAL ARTICLE
Peyton H Terry, Christopher A Campbell, Jonathan S Black, John T Stranix, Grace L Forster, Brent R DeGeorge
Introduction: Reduction mammoplasty (RM) is one of the most common operations performed in plastic surgery. While US national surgical expenditures have risen in recent years, studies have reported decreasing reimbursement rates for plastic surgeons. The purpose of this study is to characterize the trends in charges and payments for a common plastic surgery operation, ambulatory RM, for facilities and physicians. Methods: A Medicare patient records database was used to capture hospital, surgeon, and anesthesiologist charges and payments for ambulatory RM from 2005 to 2014...
February 2024: Plastic Surgery
https://read.qxmd.com/read/38418086/added-benefit-and-revenues-of-oncology-drugs-approved-by-the-european-medicines-agency-between-1995-and-2020-retrospective-cohort-study
#40
JOURNAL ARTICLE
Francine Brinkhuis, Wim G Goettsch, Aukje K Mantel-Teeuwisse, Lourens T Bloem
OBJECTIVES: To evaluate the added benefit and revenues of oncology drugs, explore their association, and investigate potential discrepancies between added benefit and revenues across different approval pathways of the European Medicines Agency (EMA). DESIGN: Retrospective cohort study. SETTING: Oncology drugs and their indications approved by the EMA between 1995 and 2020. MAIN OUTCOME MEASURES: Added benefit was evaluated using ratings published by seven organisations: health technology assessment agencies from the United States, France, Germany, and Italy, two medical oncology societies, and a drug bulletin...
February 28, 2024: BMJ: British Medical Journal
keyword
keyword
22992
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.